PMC:3750932 / 10451-10928 JSONTXT

{"project":"2_test","denotations":[{"id":"23829793-3679202-81675311","span":{"begin":72,"end":74},"obj":"3679202"},{"id":"23829793-11035689-81675312","span":{"begin":75,"end":77},"obj":"11035689"},{"id":"23829793-9117037-81675313","span":{"begin":362,"end":364},"obj":"9117037"},{"id":"23829793-17932378-81675314","span":{"begin":473,"end":475},"obj":"17932378"},{"id":"T78454","span":{"begin":72,"end":74},"obj":"3679202"},{"id":"T36215","span":{"begin":75,"end":77},"obj":"11035689"},{"id":"T35909","span":{"begin":362,"end":364},"obj":"9117037"},{"id":"T56746","span":{"begin":473,"end":475},"obj":"17932378"}],"text":"Group 1.4.2 HIV infection \nPAH is a rare complication of HIV infection [29,30]. HIV-associated PAH has clinical, hemodynamic, and histologic characteristics broadly similar to those seen in idiopathic PAH. Epidemiologic data in the early 1990s, a time when therapy with highly active antiretroviral therapy was not yet available, indicated a prevalence of 0.5% [31]. The prevalence of HIV-associated PAH was evaluated more recently and showed a stable prevalence of 0.46% [32]."}

{"project":"NEUROSES","denotations":[{"id":"T533","span":{"begin":27,"end":30},"obj":"CHEBI_33848"},{"id":"T534","span":{"begin":95,"end":98},"obj":"CHEBI_33848"},{"id":"T535","span":{"begin":201,"end":204},"obj":"CHEBI_33848"},{"id":"T536","span":{"begin":400,"end":403},"obj":"CHEBI_33848"},{"id":"T539","span":{"begin":27,"end":30},"obj":"CHEBI_31204"},{"id":"T540","span":{"begin":95,"end":98},"obj":"CHEBI_31204"},{"id":"T541","span":{"begin":201,"end":204},"obj":"CHEBI_31204"},{"id":"T542","span":{"begin":400,"end":403},"obj":"CHEBI_31204"},{"id":"T545","span":{"begin":27,"end":30},"obj":"CHEBI_53305"},{"id":"T546","span":{"begin":95,"end":98},"obj":"CHEBI_53305"},{"id":"T547","span":{"begin":201,"end":204},"obj":"CHEBI_53305"},{"id":"T548","span":{"begin":400,"end":403},"obj":"CHEBI_53305"},{"id":"T551","span":{"begin":27,"end":30},"obj":"CHEBI_104011"},{"id":"T552","span":{"begin":95,"end":98},"obj":"CHEBI_104011"},{"id":"T553","span":{"begin":201,"end":204},"obj":"CHEBI_104011"},{"id":"T554","span":{"begin":400,"end":403},"obj":"CHEBI_104011"},{"id":"T560","span":{"begin":0,"end":5},"obj":"CHEBI_24433"},{"id":"T562","span":{"begin":84,"end":94},"obj":"PATO_0001668"},{"id":"T563","span":{"begin":232,"end":237},"obj":"PATO_0000694"},{"id":"T565","span":{"begin":247,"end":251},"obj":"PATO_0000165"},{"id":"T566","span":{"begin":247,"end":251},"obj":"PATO_0001309"},{"id":"T567","span":{"begin":277,"end":283},"obj":"PATO_0002354"}],"text":"Group 1.4.2 HIV infection \nPAH is a rare complication of HIV infection [29,30]. HIV-associated PAH has clinical, hemodynamic, and histologic characteristics broadly similar to those seen in idiopathic PAH. Epidemiologic data in the early 1990s, a time when therapy with highly active antiretroviral therapy was not yet available, indicated a prevalence of 0.5% [31]. The prevalence of HIV-associated PAH was evaluated more recently and showed a stable prevalence of 0.46% [32]."}